Danaher Corp (DHR) stock saw a modest uptick, ending the day at $244.11 which represents a slight increase of $5.75 or 2.41% from the prior close of $238.36. The stock opened at $239.61 and touched a ...

Danaher Corp. closed 13.34% below its 52-week high of $281.70, which the company reached on August 1st.

Danaher (DHR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a ...

Danaher Corp (DHR) stock saw a decline, ending the day at $238.36 which represents a decrease of $-3.54 or -1.46% from the prior close of $241.9. The stock opened at $242.17 and touched a low of $238.

Danaher executed a $4.5 billion share buyback, with an additional 20 million shares authorized. Learn why I remain bullish on ...

LVW Advisors LLC trimmed its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 28.6% in the 4th quarter, Holdings ...

Arkadios Wealth Advisors trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 6.1% in the 4th quarter, ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

Washington, DC-based Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator, helping solve ...

Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker immunoassays designed to advance ...

Danaher Corporation, a key player in Life Sciences, Biotechnology, and Diagnostics, has shown mixed financial performance with recent declines in revenue and net earnings. Despite recent struggles ...

Shares of Danaher Corp. DHR advanced 1.65% to $241.90 Thursday, on what proved to be an all-around dismal trading session for ...